手術全期護理
輸血風險和考量
Blood transfusion and cancer surgery outcomes: a continued reason for concern. （開啟新視窗）
出處: Surgery 2012;152(3):344-54.
檢索: PubMed 22938895
DOI碼: 10.1016/j.surg.2012.06.008
Surgical outcomes and transfusion of minimal amounts of blood in the operating room. （開啟新視窗）
出處: Arch Surg 2012;147(1):49-55.
檢索: PubMed 22250113
DOI碼: 10.1001/archsurg.2011.790
Adverse blood transfusion outcomes: establishing causation. （開啟新視窗）
出處: Transfus Med Rev 2011;25(2):89-101.
檢索: PubMed 21345639
DOI碼: 10.1016/j.tmrv.2010.11.001
Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. （開啟新視窗）
出處: Crit Care Med 2006;34(6):1608-16.
檢索: PubMed 16607235
DOI碼: 10.1097/01.CCM.0000217920.48559.D8
Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. （開啟新視窗）
出處: Crit Care Med 2008;36(9):2667-74.
檢索: PubMed 18679112
DOI碼: 10.1097/CCM.0b013e3181844677
Survival rate changes with transfusion of blood products during liver transplantation. （開啟新視窗）
出處: Can J Anaesth 2005;52(2):148-55.
檢索: PubMed 15684254
DOI碼: 10.1007/BF03027720
Emerging infectious disease agents and their potential threat to transfusion safety. （開啟新視窗）
出處: Transfusion 2009;49 Suppl 2:1S-29S.
檢索: PubMed 19686562
DOI碼: 10.1111/j.1537-2995.2009.02279.x
Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. （開啟新視窗）
出處: ISBT Sci Ser 2014;9(1):30-6.
檢索: PubMed 25210533
DOI碼: 10.1111/voxs.12070
